Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2012-05-03

Clinical Trial Update: Heart Pressure Assessment Study With Tolvaptan to Treat Congestive Heart Failure [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating tolvaptan for congestive heart failure has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Samsca (tolvaptan)

Snippet

Sponsor: Otsuka Pharmaceutical Development & Commercialization, Inc. | Conditions: Heart Failure, Congestive | Phase 2 | Status: COMPLETED